N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Gunasekaran P, Shin SC, Hwang YS, Lee J, et al. Pharmaceutics 2025;17:1027.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gunasekaran P, Shin SC, Hwang YS, Lee J, et al. N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics 2025;17:1027.
PMID: 40871048